Cargando…

PB2071: INTRALESIONAL RITUXIMAB IN THE TREATMENT OF PRIMARY CUTANEOUS B-CELL LYMPHOMA

Detalles Bibliográficos
Autores principales: Callejas Charavia, M., Castilla García, L., Aspa, J., García Ramírez, P., Argüello Marina, M., Martínez Vázquez, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431481/
http://dx.doi.org/10.1097/01.HS9.0000851116.95955.a3
_version_ 1784780067682910208
author Callejas Charavia, M.
Castilla García, L.
Aspa, J.
García Ramírez, P.
Argüello Marina, M.
Martínez Vázquez, C.
author_facet Callejas Charavia, M.
Castilla García, L.
Aspa, J.
García Ramírez, P.
Argüello Marina, M.
Martínez Vázquez, C.
author_sort Callejas Charavia, M.
collection PubMed
description
format Online
Article
Text
id pubmed-9431481
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94314812022-08-31 PB2071: INTRALESIONAL RITUXIMAB IN THE TREATMENT OF PRIMARY CUTANEOUS B-CELL LYMPHOMA Callejas Charavia, M. Castilla García, L. Aspa, J. García Ramírez, P. Argüello Marina, M. Martínez Vázquez, C. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431481/ http://dx.doi.org/10.1097/01.HS9.0000851116.95955.a3 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Callejas Charavia, M.
Castilla García, L.
Aspa, J.
García Ramírez, P.
Argüello Marina, M.
Martínez Vázquez, C.
PB2071: INTRALESIONAL RITUXIMAB IN THE TREATMENT OF PRIMARY CUTANEOUS B-CELL LYMPHOMA
title PB2071: INTRALESIONAL RITUXIMAB IN THE TREATMENT OF PRIMARY CUTANEOUS B-CELL LYMPHOMA
title_full PB2071: INTRALESIONAL RITUXIMAB IN THE TREATMENT OF PRIMARY CUTANEOUS B-CELL LYMPHOMA
title_fullStr PB2071: INTRALESIONAL RITUXIMAB IN THE TREATMENT OF PRIMARY CUTANEOUS B-CELL LYMPHOMA
title_full_unstemmed PB2071: INTRALESIONAL RITUXIMAB IN THE TREATMENT OF PRIMARY CUTANEOUS B-CELL LYMPHOMA
title_short PB2071: INTRALESIONAL RITUXIMAB IN THE TREATMENT OF PRIMARY CUTANEOUS B-CELL LYMPHOMA
title_sort pb2071: intralesional rituximab in the treatment of primary cutaneous b-cell lymphoma
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431481/
http://dx.doi.org/10.1097/01.HS9.0000851116.95955.a3
work_keys_str_mv AT callejascharaviam pb2071intralesionalrituximabinthetreatmentofprimarycutaneousbcelllymphoma
AT castillagarcial pb2071intralesionalrituximabinthetreatmentofprimarycutaneousbcelllymphoma
AT aspaj pb2071intralesionalrituximabinthetreatmentofprimarycutaneousbcelllymphoma
AT garciaramirezp pb2071intralesionalrituximabinthetreatmentofprimarycutaneousbcelllymphoma
AT arguellomarinam pb2071intralesionalrituximabinthetreatmentofprimarycutaneousbcelllymphoma
AT martinezvazquezc pb2071intralesionalrituximabinthetreatmentofprimarycutaneousbcelllymphoma